SouthState Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
SouthState Corp's BIIB Position: Q2 2026 in Review
SouthState Corp increased its Biogen (BIIB) stake by 83% in Q2 2026, buying an estimated $3.63K and bringing the position to 42 shares worth $9.07K. The position accounts for ﹤0.01% of the portfolio, ranked #717.
SouthState Corp first reported a position in BIIB in Q1 2017 and has held it in 19 quarters since. The position peaked at $403K in Q1 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- SouthState Corp held 42 shares of Biogen worth $9.07K as of Q2 2026.
- SouthState Corp bought 19 Biogen shares in Q2 2026, an estimated $3.63K.
- Biogen made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #717 holding.
- SouthState Corp first reported a position in Biogen in Q1 2017 and has held it in 19 quarters since.
- SouthState Corp's Biogen position peaked at $403K in Q1 2017.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.